{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:50:34Z","timestamp":1791312634579,"version":"4.3.1"},"reference-count":238,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","award":["26826"],"award-info":[{"award-number":["26826"]}],"id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009670","name":"National Alliance for Research on Schizophrenia and Depression","doi-asserted-by":"publisher","award":["EXCELLENCE\/0421\/0543"],"award-info":[{"award-number":["EXCELLENCE\/0421\/0543"]}],"id":[{"id":"10.13039\/100009670","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.pbb.2023.173531","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T12:17:08Z","timestamp":1677241028000},"page":"173531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Role of group II metabotropic glutamate receptors in ketamine's antidepressant actions"],"prefix":"10.1016","volume":"223","author":[{"given":"Anna","family":"Onisiforou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polymnia","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panos","family":"Zanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pbb.2023.173531_bb0005","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41386-020-0644-9","article-title":"Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin","volume":"45","author":"Abdallah","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2023.173531_bb0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pharmthera.2018.05.010","article-title":"The neurobiology of depression, ketamine and rapid-acting antidepressants: is it glutamate inhibition or activation?","volume":"190","author":"Abdallah","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"19","key":"10.1016\/j.pbb.2023.173531_bb0015","doi-asserted-by":"crossref","first-page":"13361","DOI":"10.1016\/S0021-9258(18)42219-3","article-title":"Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate\/Ca2+ signal transduction","volume":"267","author":"Abe","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbb.2023.173531_bb0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuropharm.2012.09.008","article-title":"Metabotropic glutamate 2\/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice","volume":"65","author":"Ago","year":"2013","journal-title":"Neuropharmacology"},{"issue":"7845","key":"10.1016\/j.pbb.2023.173531_bb0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-020-03047-0","article-title":"Antidepressant actions of ketamine engage cell-specific translation via eIF4E","volume":"590","author":"Aguilar-Valles","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2023.173531_bb0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bbr.2014.05.003","article-title":"Blockade of the metabotropic glutamate (mGluR2) modulates arousal through vigilance states transitions: evidence from sleep\u2013wake EEG in rodents","volume":"270","author":"Ahnaou","year":"2014","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13041-020-00627-z","article-title":"Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the wistar-Kyoto rat model of depression","volume":"13","author":"Aleksandrova","year":"2020","journal-title":"Mol. Brain"},{"issue":"10","key":"10.1016\/j.pbb.2023.173531_bb0040","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1046\/j.1460-9568.2003.02657.x","article-title":"Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins","volume":"17","author":"Aronica","year":"2003","journal-title":"Eur. J. Neurosci."},{"issue":"7354","key":"10.1016\/j.pbb.2023.173531_bb0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pbb.2023.173531_bb0050","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pr.111.005108","article-title":"Brain-derived neurotrophic factor and neuropsychiatric disorders","volume":"64","author":"Autry","year":"2012","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.pbb.2023.173531_bb0055","first-page":"340","article-title":"Intranasal esketamine (Spravato(TM)) for use in treatment-resistant depression in conjunction with an Oral antidepressant","volume":"44","author":"Bahr","year":"2019","journal-title":"P t"},{"key":"10.1016\/j.pbb.2023.173531_bb0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ynstr.2017.05.001","article-title":"Circuit and synaptic mechanisms of repeated stress: perspectives from differing contexts, duration, and development","volume":"7","author":"Bath","year":"2017","journal-title":"Neurobiol. Stress"},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb0065","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0070","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2008.06.089","article-title":"Behavioral characterization of the mGlu group II\/III receptor antagonist, LY-341495, in animal models of anxiety and depression","volume":"592","author":"Bespalov","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173531_bb0075","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","article-title":"BDNF - a key transducer of antidepressant effects","volume":"102","author":"Bj\u00f6rkholm","year":"2016","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.pbb.2023.173531_bb0080","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3109\/15622971003611319","article-title":"Serum and plasma BDNF levels in major depression: a replication study and meta-analyses","volume":"11","author":"Bocchio-Chiavetto","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.pbb.2023.173531_bb0085","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1038\/s41380-022-01673-w","article-title":"Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search","volume":"27","author":"Bonaventura","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.pbb.2023.173531_bb0090","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/ajp.154.6.805","article-title":"Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers","volume":"154","author":"Breier","year":"1997","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.pbb.2023.173531_bb0095","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/npp.2012.246","article-title":"GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects","volume":"38","author":"Burgdorf","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2023.173531_bb0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-neuro-062111-150444","article-title":"Mechanisms of gamma oscillations","volume":"35","author":"Buzs\u00e1ki","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb0105","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nn.3355","article-title":"Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression","volume":"16","author":"Cai","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pbb.2023.173531_bb0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuropharm.2012.12.009","article-title":"Sex differences in the antidepressant-like effects of ketamine","volume":"70","author":"Carrier","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2023.173531_bb0115","doi-asserted-by":"crossref","first-page":"1032224","DOI":"10.3389\/fnmol.2022.1032224","article-title":"BDNF receptor TrkB as the mediator of the antidepressant drug action","volume":"15","author":"Casarotto","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.pbb.2023.173531_bb0120","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","article-title":"Antidepressant drugs act by directly binding to TRKB neurotrophin receptors","volume":"184","author":"Casarotto","year":"2021","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.pbb.2023.173531_bb0125","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/mp.2017.61","article-title":"Neuronal plasticity and neurotrophic factors in drug responses","volume":"22","author":"Castren","year":"2017","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coph.2006.08.009","article-title":"Role of neurotrophic factors in depression","volume":"7","author":"Castren","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173531_bb0135","author":"Cerecor"},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb0140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.neuropharm.2003.10.009","article-title":"MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity","volume":"46","author":"Chaki","year":"2004","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.pbb.2023.173531_bb0145","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/s41386-020-0714-z","article-title":"Sex-specific neurobiological actions of prophylactic (R, S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine","volume":"45","author":"Chen","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.pbb.2023.173531_bb0150","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1523\/JNEUROSCI.21-11-03705.2001","article-title":"Time-dependent reversal of long-term potentiation by low-frequency stimulation at the hippocampal mossy fiber\u2013CA3 synapses","volume":"21","author":"Chen","year":"2001","journal-title":"J. Neurosci."},{"issue":"5796","key":"10.1016\/j.pbb.2023.173531_bb0155","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1126\/science.1129663","article-title":"Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior","volume":"314","author":"Chen","year":"2006","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.pbb.2023.173531_bb0160","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/jpet.110.173880","article-title":"Awake rat pharmacological magnetic resonance imaging as a translational pharmacodynamic biomarker: metabotropic glutamate 2\/3 agonist modulation of ketamine-induced blood oxygenation level dependence signals","volume":"336","author":"Chin","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2023.173531_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108068","article-title":"Brain-derived neurotrophic factor in the ventrolateral periaqueductal gray contributes to (2R,6R)-hydroxynorketamine-mediated actions","volume":"170","author":"Chou","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2023.173531_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2018.06.033","article-title":"(2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray","volume":"139","author":"Chou","year":"2018","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0175","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/mp.2016.34","article-title":"Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects","volume":"22","author":"Chowdhury","year":"2017","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb0180","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/(SICI)1098-1136(199712)21:4<390::AID-GLIA6>3.0.CO;2-7","article-title":"Opposite influence of the metabotropic glutamate receptor subtypes mGlu3 and -5 on astrocyte proliferation in culture","volume":"21","author":"Ciccarelli","year":"1997","journal-title":"Glia"},{"issue":"16","key":"10.1016\/j.pbb.2023.173531_bb0185","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/WNR.0000000000001131","article-title":"(2R,6R)-hydroxynorketamine promotes dendrite outgrowth in human inducible pluripotent stem cell-derived neurons through AMPA receptor with timing and exposure compatible with ketamine infusion pharmacokinetics in humans","volume":"29","author":"Collo","year":"2018","journal-title":"Neuroreport"},{"issue":"30","key":"10.1016\/j.pbb.2023.173531_bb0190","doi-asserted-by":"crossref","first-page":"9761","DOI":"10.1523\/JNEUROSCI.23-30-09761.2003","article-title":"Gamma oscillations induced by kainate receptor activation in the entorhinal cortex in vitro","volume":"23","author":"Cunningham","year":"2003","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.pbb.2023.173531_bb0195","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00213-010-2052-z","article-title":"Memantine-induced brain activation as a model for the rapid screening of potential novel antipsychotic compounds: exemplified by activity of an mGlu2\/3 receptor agonist","volume":"214","author":"Dedeurwaerdere","year":"2011","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2023.173531_bb0200","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn2055","article-title":"Regulatory mechanisms of AMPA receptors in synaptic plasticity","volume":"8","author":"Derkach","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"8","key":"10.1016\/j.pbb.2023.173531_bb0205","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"issue":"12","key":"10.1016\/j.pbb.2023.173531_bb0210","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4088\/JCP.09m05327blu","article-title":"Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder","volume":"71","author":"DiazGranados","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.pbb.2023.173531_bb0215","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1399-5618.2012.00997.x","article-title":"Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta-analysis","volume":"14","author":"Dierckx","year":"2012","journal-title":"Bipolar Disord."},{"issue":"3","key":"10.1016\/j.pbb.2023.173531_bb0220","first-page":"228","article-title":"Rapid and sustained antidepressant action of the mGlu2\/3 receptor antagonist MGS0039 in the social defeat stress model: comparison with ketamine","volume":"20","author":"Dong","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.pbb.2023.173531_bb0225","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.euroneuro.2016.03.006","article-title":"Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate","volume":"26","author":"Downey","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.31887\/DCNS.2014.16.1\/rduman","article-title":"Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections","volume":"16","author":"Duman","year":"2014","journal-title":"Dialogues Clin. Neurosci."},{"issue":"6103","key":"10.1016\/j.pbb.2023.173531_bb0235","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.1222939","article-title":"Synaptic dysfunction in depression: potential therapeutic targets","volume":"338","author":"Duman","year":"2012","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.pbb.2023.173531_bb0240","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.pbb.2023.173531_bb0245","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archpsyc.1997.01830190015002","article-title":"A molecular and cellular theory of depression","volume":"54","author":"Duman","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0250","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuropharm.2011.08.044","article-title":"Signaling pathways underlying the rapid antidepressant actions of ketamine","volume":"62","author":"Duman","year":"2012","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0255","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuron.2019.03.013","article-title":"Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments","volume":"102","author":"Duman","year":"2019","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb0260","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1017\/S1461145711001702","article-title":"mTOR activation is required for the antidepressant effects of mGluR(2)\/(3) blockade","volume":"15","author":"Dwyer","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0265","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2049-9256-1-15","article-title":"mGluR2\/3 blockade produces rapid and long-lasting reversal of anhedonia caused by chronic stress exposure","volume":"1","author":"Dwyer","year":"2013","journal-title":"J. Mol. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173531_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110033","article-title":"Modulation by chronic stress and ketamine of ionotropic AMPA\/NMDA and metabotropic glutamate receptors in the rat hippocampus","volume":"104","author":"Elhussiny","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173531_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172973","article-title":"Ketamine metabolite (2R,6R)-hydroxynorketamine reverses behavioral despair produced by adolescent trauma","volume":"196","author":"Elmer","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2023.173531_bb0280","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0079-6123(08)60453-7","article-title":"The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease","volume":"116","author":"Farber","year":"1998","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.pbb.2023.173531_bb0285","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pbb.2014.03.001","article-title":"The effect of ((-)-2-oxa-4-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY379268), an mGlu2\/3 receptor agonist, on EEG power spectra and coherence in ketamine model of psychosis","volume":"122","author":"Fujakova","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0290","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1073\/pnas.1814709116","article-title":"Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine","volume":"116","author":"Fukumoto","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.pbb.2023.173531_bb0295","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s00213-013-3378-0","volume":"231","author":"Fukumoto","year":"2014","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0300","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.116.239228","article-title":"Antidepressant potential of (R)-ketamine in rodent models: comparison with (S)-ketamine","volume":"361","author":"Fukumoto","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0305","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pnpbp.2007.07.027","article-title":"Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus","volume":"32","author":"Garcia","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.pbb.2023.173531_bb0310","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4088\/JCP.v61n1002","article-title":"How fast are antidepressants?","volume":"61","author":"Gelenberg","year":"2000","journal-title":"J. Clin. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.pbb.2023.173531_bb0315","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0006-8993(93)90811-Z","article-title":"Characterization of metabotropic glutamate receptors negatively linked to adenylyl cyclase in brain slices","volume":"622","author":"Genazzani","year":"1993","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.pbb.2023.173531_bb0320","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/s41593-022-01146-x","article-title":"Experimenters' sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor","volume":"25","author":"Georgiou","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0325","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/npp.2016.210","article-title":"Ketamine mechanism of action: separating the wheat from the chaff","volume":"42","author":"Gould","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2023.173531_bb0330","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev-pharmtox-010617-052811","article-title":"Molecular pharmacology and neurobiology of rapid-acting antidepressants","volume":"59","author":"Gould","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.pbb.2023.173531_bb0335","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.neuron.2011.08.007","article-title":"Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo","volume":"71","author":"Gray","year":"2011","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.pbb.2023.173531_bb0340","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1176\/appi.neuropsych.15030053","article-title":"The links between stress and depression: psychoneuroendocrinological, genetic, and environmental interactions","volume":"28","author":"Tafet","year":"2016","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"3","key":"10.1016\/j.pbb.2023.173531_bb0345","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/mp.2015.211","article-title":"Antidepressant action of ketamine via mTOR is mediated by inhibition of nitrergic rheb degradation","volume":"21","author":"Harraz","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"16","key":"10.1016\/j.pbb.2023.173531_bb0350","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.pbb.2023.173531_bb0355","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1476-5381.1992.tb12780.x","article-title":"Agonist analysis of 2-(carboxycyclopropyl)glycine isomers for cloned metabotropic glutamate receptor subtypes expressed in chinese hamster ovary cells","volume":"107","author":"Hayashi","year":"1992","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.pbb.2023.173531_bb0360","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrn.2016.37","article-title":"Synaptic AMPA receptor composition in development, plasticity and disease","volume":"17","author":"Henley","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"issue":"Pt 3","key":"10.1016\/j.pbb.2023.173531_bb0365","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/bj3590465","article-title":"Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors","volume":"359","author":"Hermans","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.pbb.2023.173531_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2021.100404","article-title":"Longitudinal CSF proteome profiling in mice to uncover the acute and sustained mechanisms of action of rapid acting antidepressant (2R,6R)-hydroxynorketamine (HNK)","volume":"15","author":"Herzog","year":"2021","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.pbb.2023.173531_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114892","article-title":"Mechanisms of ketamine and its metabolites as antidepressants","volume":"197","author":"Hess","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb0380","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1021\/acschemneuro.1c00761","article-title":"Hydroxynorketamine pharmacokinetics and antidepressant behavioral effects of (2,6)- and (5R)-methyl-(2R,6R)-hydroxynorketamines","volume":"13","author":"Highland","year":"2022","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0385","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/0269881118812095","article-title":"Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R,6R)-hydroxynorketamine","volume":"33","author":"Highland","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.pbb.2023.173531_bb0390","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/s41386-019-0380-1","article-title":"Group II metabotropic glutamate receptor blockade promotes stress resilience in mice","volume":"44","author":"Highland","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2023.173531_bb0395","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1124\/pharmrev.120.000149","article-title":"Hydroxynorketamines: pharmacology and potential therapeutic applications","volume":"73","author":"Highland","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pbb.2023.173531_bb0400","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2014.03.025","article-title":"Metabotropic glutamate receptors regulate cortical gamma hyperactivities elicited by ketamine in rats","volume":"567","author":"Hiyoshi","year":"2014","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.pbb.2023.173531_bb0405","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tins.2009.11.003","article-title":"mTOR signaling: at the crossroads of plasticity, memory and disease","volume":"33","author":"Hoeffer","year":"2010","journal-title":"Trends Neurosci."},{"issue":"11","key":"10.1016\/j.pbb.2023.173531_bb0410","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00213-016-4256-3","article-title":"Rapamycin blocks the antidepressant effect of ketamine in task-dependent manner","volume":"233","author":"Holubova","year":"2016","journal-title":"Psychopharmacology"},{"issue":"43","key":"10.1016\/j.pbb.2023.173531_bb0415","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons","volume":"27","author":"Homayoun","year":"2007","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.pbb.2023.173531_bb0420","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1192\/bjp.2020.89","article-title":"Are we repeating mistakes of the past? A review of the evidence for esketamine","volume":"219","author":"Horowitz","year":"2021","journal-title":"Br. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.pbb.2023.173531_bb0425","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1200\/JCO.2004.11.054","article-title":"Secondary leukemias in refractory germ cell tumor patients undergoing autologous stem-cell transplantation using high-dose etoposide","volume":"22","author":"Houck","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.pbb.2023.173531_bb0430","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.neuron.2013.10.025","article-title":"AMPARs and synaptic plasticity: the last 25 years","volume":"80","author":"Huganir","year":"2013","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb0435","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4088\/JCP.v65n0406","article-title":"Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a consortium for research in ECT (CORE) report","volume":"65","author":"Husain","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.pbb.2023.173531_bb0440","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1471-4159.2002.00929.x","article-title":"Native group-III metabotropic glutamate receptors are coupled to the mitogen-activated protein kinase\/phosphatidylinositol-3-kinase pathways","volume":"82","author":"Iacovelli","year":"2002","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.pbb.2023.173531_bb0445","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/npp.2011.338","article-title":"Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study","volume":"37","author":"Ibrahim","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2023.173531_bb0450","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/JCP.0b013e31825d70d6","article-title":"A randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder","volume":"32","author":"Ibrahim","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.pbb.2023.173531_bb0455","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/0896-6273(95)90341-0","article-title":"Heterologous expression of metabotropic glutamate receptors in adult rat sympathetic neurons: subtype-specific coupling to ion channels","volume":"14","author":"Ikeda","year":"1995","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0460","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2006.06.037","article-title":"Subchronic administration of LY354740 does not modify ketamine-evoked behavior and neuronal activity in rats","volume":"544","author":"Imre","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.pbb.2023.173531_bb0465","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.pbb.2006.05.021","article-title":"Effects of the mGluR2\/3 agonist LY379268 on ketamine-evoked behaviours and neurochemical changes in the dentate gyrus of the rat","volume":"84","author":"Imre","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0470","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.mp.4001777","article-title":"Cure therapeutics and strategic prevention: raising the bar for mental health research","volume":"11","author":"Insel","year":"2006","journal-title":"Mol. Psychiatry"},{"issue":"11","key":"10.1016\/j.pbb.2023.173531_bb0475","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1176\/ps.2009.60.11.1466","article-title":"The STAR*D trial: revealing the need for better treatments","volume":"60","author":"Insel","year":"2009","journal-title":"Psychiatr. Serv."},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0480","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41386-018-0192-8","article-title":"Antidepressant potential of metabotropic glutamate receptor mGlu(2) and mGlu(3) negative allosteric modulators","volume":"44","author":"Joffe","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0485","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12888-022-03838-x","article-title":"BDNF-TrkB signaling-mediated upregulation of narp is involved in the antidepressant-like effects of (2R,6R)-hydroxynorketamine in a chronic restraint stress mouse model","volume":"22","author":"Ju","year":"2022","journal-title":"BMC Psychiatry"},{"issue":"6","key":"10.1016\/j.pbb.2023.173531_bb0490","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jamapsychiatry.2015.0071","article-title":"Large-scale network dysfunction in major depressive disorder: a meta-analysis of resting-state functional connectivity","volume":"72","author":"Kaiser","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0495","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2005.02.032","article-title":"AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist","volume":"1042","author":"Karasawa","year":"2005","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.pbb.2023.173531_bb0500","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jpsychires.2012.09.017","article-title":"Diagnostic accuracy of serum brain derived neurotrophic factor concentration in antidepressant naive patients with first major depression episode","volume":"47","author":"Karlovic","year":"2013","journal-title":"J. Psychiatr. Res."},{"issue":"5290","key":"10.1016\/j.pbb.2023.173531_bb0505","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1126\/science.274.5290.1133","article-title":"Synaptic activity and the construction of cortical circuits","volume":"274","author":"Katz","year":"1996","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.pbb.2023.173531_bb0510","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archpsyc.63.12.1337","article-title":"Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the consortium for research in electroconvulsive therapy (CORE)","volume":"63","author":"Kellner","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"7","key":"10.1016\/j.pbb.2023.173531_bb0515","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archgenpsychiatry.2011.60","article-title":"Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder","volume":"68","author":"Kempton","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"23","key":"10.1016\/j.pbb.2023.173531_bb0520","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.pbb.2023.173531_bb0525","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1017\/S0033291716000064","article-title":"Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories","volume":"46","author":"Kishimoto","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pbb.2023.173531_bb0530","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbr.2014.05.065","article-title":"Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats","volume":"271","author":"Koike","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2023.173531_bb0535","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbr.2012.10.023","article-title":"Role of BDNF\/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression","volume":"238","author":"Koike","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0540","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2011.05.035","article-title":"Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression","volume":"224","author":"Koike","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.pbb.2023.173531_bb0545","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s43440-020-00097-z","article-title":"Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials","volume":"72","author":"Kryst","year":"2020","journal-title":"Pharmacol. Rep."},{"issue":"11","key":"10.1016\/j.pbb.2023.173531_bb0550","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.biopsych.2012.05.031","article-title":"Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients","volume":"72","author":"Laje","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.pbb.2023.173531_bb0555","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.105","article-title":"Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression","volume":"4","author":"Lally","year":"2014","journal-title":"Transl. Psychiatry"},{"issue":"12","key":"10.1016\/j.pbb.2023.173531_bb0560","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.biopsych.2014.03.026","article-title":"A randomized controlled trial of intranasal ketamine in major depressive disorder","volume":"76","author":"Lapidus","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.pbb.2023.173531_bb0565","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1162\/jocn.2009.21305","article-title":"Ketamine modulates theta and gamma oscillations","volume":"22","author":"Lazarewicz","year":"2010","journal-title":"J. Cogn. Neurosci."},{"issue":"5","key":"10.1016\/j.pbb.2023.173531_bb0570","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10051005","article-title":"Neurobiology of depression: chronic stress alters the glutamatergic system in the brain-focusing on AMPA receptor","volume":"10","author":"Lee","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.pbb.2023.173531_bb0575","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neuropharm.2016.09.011","article-title":"Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures","volume":"111","author":"Lepack","year":"2016","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0580","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu033","article-title":"BDNF release is required for the behavioral actions of ketamine","volume":"18","author":"Lepack","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"5994","key":"10.1016\/j.pbb.2023.173531_bb0585","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.pbb.2023.173531_bb0590","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/npp.2016.202","article-title":"GLYX-13 produces rapid antidepressant responses with key synaptic and behavioral effects distinct from ketamine","volume":"42","author":"Liu","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.pbb.2023.173531_bb0595","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.biopsych.2011.09.030","article-title":"Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex","volume":"71","author":"Liu","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pbb.2023.173531_bb0600","doi-asserted-by":"crossref","DOI":"10.1088\/1478-3975\/7\/2\/021001","article-title":"Mechanisms governing the control of mRNA translation","volume":"7","author":"Livingstone","year":"2010","journal-title":"Phys. Biol."},{"issue":"3","key":"10.1016\/j.pbb.2023.173531_bb0605","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0306-4522(02)00652-8","article-title":"Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268","volume":"117","author":"Lorrain","year":"2003","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.pbb.2023.173531_bb0610","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1073\/pnas.1816071116","article-title":"Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function","volume":"116","author":"Lumsden","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb0615","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pbb.2023.173531_bb0620","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1523\/JNEUROSCI.20-02-00771.2000","article-title":"BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain","volume":"20","author":"Mamounas","year":"2000","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.pbb.2023.173531_bb0625","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/sj.mp.4000811","article-title":"Neuroplasticity and cellular resilience in mood disorders","volume":"5","author":"Manji","year":"2000","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.pbb.2023.173531_bb0630","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0006-3223(03)00117-3","article-title":"Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression","volume":"53","author":"Manji","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173531_bb0635","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jad.2020.09.007","article-title":"A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: january 2009 - january 2019","volume":"277","author":"Marcantoni","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb0640","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0026-895X(25)09393-9","article-title":"Functional coupling of rat group II metabotropic glutamate receptors to an omega-conotoxin GVIA-sensitive calcium channel in human embryonic kidney 293 cells","volume":"50","author":"McCool","year":"1996","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb0645","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1017\/S0033291714001603","article-title":"A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes","volume":"45","author":"McGirr","year":"2015","journal-title":"Psychol. Med."},{"issue":"7","key":"10.1016\/j.pbb.2023.173531_bb0650","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00213-018-4877-9","article-title":"Group II metabotropic glutamate receptor agonist prodrugs LY2979165 and LY2140023 attenuate the functional imaging response to ketamine in healthy subjects","volume":"235","author":"Mehta","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2023.173531_bb0655","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03581","article-title":"GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine","volume":"3","author":"Miller","year":"2014","journal-title":"elife"},{"issue":"9","key":"10.1016\/j.pbb.2023.173531_bb0660","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/EJA.0000000000000638","article-title":"History of anaesthesia: the ketamine story - past, present and future","volume":"34","author":"Mion","year":"2017","journal-title":"Eur. J. Anaesthesiol."},{"issue":"1\u20133","key":"10.1016\/j.pbb.2023.173531_bb0665","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejphar.2012.11.023","article-title":"Sub-anesthetic concentrations of (R, S)-ketamine metabolites inhibit acetylcholine-evoked currents in alpha7 nicotinic acetylcholine receptors","volume":"698","author":"Moaddel","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.pbb.2023.173531_bb0670","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.pbb.2023.173531_bb0675","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/mp.2010.98","article-title":"Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment","volume":"16","author":"Molendijk","year":"2011","journal-title":"Mol. Psychiatry"},{"issue":"12","key":"10.1016\/j.pbb.2023.173531_bb0680","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.biopsych.2012.09.006","article-title":"The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine","volume":"73","author":"Monteggia","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"17","key":"10.1016\/j.pbb.2023.173531_bb0685","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1021\/acs.orglett.7b02177","article-title":"Synthesis and N-methyl-d-aspartate (NMDA) receptor activity of ketamine metabolites","volume":"19","author":"Morris","year":"2017","journal-title":"Org. Lett."},{"issue":"7","key":"10.1016\/j.pbb.2023.173531_bb0690","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrd.2017.16","article-title":"Targeting glutamate signalling in depression: progress and prospects","volume":"16","author":"Murrough","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.pbb.2023.173531_bb0695","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"issue":"16","key":"10.1016\/j.pbb.2023.173531_bb0700","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1017\/S0033291715001506","article-title":"Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial","volume":"45","author":"Murrough","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pbb.2023.173531_bb0705","article-title":"Functional and structural remodeling of glutamate synapses in prefrontal and frontal cortex induced by behavioral stress","volume":"6","author":"Musazzi","year":"2015","journal-title":"FrontPsychiatry"},{"issue":"33","key":"10.1016\/j.pbb.2023.173531_bb0710","doi-asserted-by":"crossref","first-page":"11694","DOI":"10.1523\/JNEUROSCI.0903-15.2015","article-title":"Evidence that subanesthetic doses of ketamine cause sustained disruptions of NMDA and AMPA-mediated frontoparietal connectivity in humans","volume":"35","author":"Muthukumaraswamy","year":"2015","journal-title":"J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.pbb.2023.173531_bb0715","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0006-8993(02)03375-9","article-title":"NMDA receptor-mediated mechanism of ketamine-induced facilitation of glutamatergic excitatory synaptic transmission","volume":"953","author":"Narimatsu","year":"2002","journal-title":"Brain Res."},{"issue":"10","key":"10.1016\/j.pbb.2023.173531_bb0720","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","volume":"172","author":"Newport","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173531_bb0725","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: physiology, pharmacology, and disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb0730","first-page":"208","article-title":"Quantifying the speed of symptomatic improvement with electroconvulsive therapy: comparison of alternative statistical methods","volume":"13","author":"Nobler","year":"1997","journal-title":"Convuls. Ther."},{"issue":"16","key":"10.1016\/j.pbb.2023.173531_bb0735","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.1523\/JNEUROSCI.4998-12.2013","article-title":"Acute suppression of spontaneous neurotransmission drives synaptic potentiation","volume":"33","author":"Nosyreva","year":"2013","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0740","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0896-6273(94)90459-6","article-title":"Immunohistochemical localization of metabotropic glutamate receptors, mGluR2 and mGluR3, in rat cerebellar cortex","volume":"13","author":"Ohishi","year":"1994","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.pbb.2023.173531_bb0745","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/cne.903350209","article-title":"Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study","volume":"335","author":"Ohishi","year":"1993","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pbb.2023.173531_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173454","article-title":"The role of mGlu2\/3 receptor antagonists in the enhancement of the antidepressant-like effect of ketamine","volume":"220","author":"Pa\u0142ucha-Poniewiera","year":"2022","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb0755","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19r12889","article-title":"Efficacy of esketamine augmentation in major depressive disorder: a meta-analysis","volume":"81","author":"Papakostas","year":"2020","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.pbb.2023.173531_bb0760","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/ijnp\/pyaa025","article-title":"A randomized trial of the N-methyl-d-aspartate receptor glycine site antagonist prodrug 4-chlorokynurenine in treatment-resistant depression","volume":"23","author":"Park","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2023.173531_bb0765","series-title":"National Network of Depression Centers Annual Conference. Ann Arbor, Michigan","article-title":"A randomized, double- blind, placebo-controlled, sequential parallel study of CERC-301 in the adjunctive treatment of subjects with severe depression and recent active suicidal ideation despite antidepressant treatment","author":"Paterson","year":"2015"},{"issue":"7","key":"10.1016\/j.pbb.2023.173531_bb0770","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1523\/JNEUROSCI.5205-11.2012","article-title":"The BDNF Val66Met polymorphism impairs synaptic transmission and plasticity in the infralimbic medial prefrontal cortex","volume":"32","author":"Pattwell","year":"2012","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0775","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/ALN.0000000000000285","article-title":"(R, S)-ketamine metabolites (R, S)-norketamine and (2S,6S)-hydroxynorketamine increase the mammalian target of rapamycin (mTOR) function","volume":"121","author":"Paul","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pbb.2023.173531_bb0780","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbrc.2022.01.025","article-title":"Periaqueductal gray is required for controlling chronic stress-induced depression-like behavior","volume":"593","author":"Peng","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb0785","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0306-4522(95)00533-1","article-title":"The metabotropic glutamate receptors, MGLUR2 and MGLUR3, show unique postsynaptic, presynaptic and glial localizations","volume":"71","author":"Petralia","year":"1996","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0790","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.biopsych.2017.10.020","article-title":"Common neurotransmission recruited in (R, S)-ketamine and (2R,6R)-hydroxynorketamine-induced sustained antidepressant-like effects","volume":"84","author":"Pham","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"15\u201316","key":"10.1016\/j.pbb.2023.173531_bb0795","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1007\/s00213-016-4325-7","article-title":"Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats","volume":"233","author":"Podkowa","year":"2016","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0800","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/35049004","article-title":"Neurotrophins as synaptic modulators","volume":"2","author":"Poo","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0805","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrn3138","article-title":"The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission","volume":"13","author":"Popoli","year":"2011","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0810","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0165-1781(87)90045-X","article-title":"Differential time course of antidepressant effects after sleep deprivation, ECT, and carbamazepine: clinical and theoretical implications","volume":"22","author":"Post","year":"1987","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb2000","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2019.12.011","article-title":"Antidepressant effects and mechanisms of group II mGlu receptor-specific negative allosteric modulators","volume":"105","author":"Potter","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.pbb.2023.173531_bb0815","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/JCP.0b013e31818a6cea","article-title":"An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder","volume":"28","author":"Preskorn","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"17","key":"10.1016\/j.pbb.2023.173531_bb0820","doi-asserted-by":"crossref","first-page":"8040","DOI":"10.1073\/pnas.89.17.8040","article-title":"Characterization of a metabotropic glutamate receptor: direct negative coupling to adenylyl cyclase and involvement of a pertussis toxin-sensitive G protein","volume":"89","author":"Prezeau","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb0825","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/da.22253","article-title":"Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression","volume":"31","author":"Price","year":"2014","journal-title":"Depress Anxiety"},{"issue":"2","key":"10.1016\/j.pbb.2023.173531_bb0830","doi-asserted-by":"crossref","DOI":"10.3390\/ph15020125","article-title":"Combined administration of (R)-ketamine and the mGlu2\/3 receptor antagonist LY341495 induces rapid and sustained effects in the CUMS model of depression via a TrkB\/BDNF-dependent mechanism","volume":"15","author":"Rafa\u0142o-Uli\u0144ska","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1473","key":"10.1016\/j.pbb.2023.173531_bb0835","first-page":"1545","article-title":"Neurotrophin-regulated signalling pathways","volume":"361","author":"Reichardt","year":"2006","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"issue":"2","key":"10.1016\/j.pbb.2023.173531_bb0840","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41386-019-0443-3","article-title":"(2R,6R)-hydroxynorketamine rapidly potentiates hippocampal glutamatergic transmission through a synapse-specific presynaptic mechanism","volume":"45","author":"Riggs","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2023.173531_bb0845","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev-clinpsy-072120-014126","article-title":"Ketamine and the future of rapid-acting antidepressants","volume":"17","author":"Riggs","year":"2021","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.pbb.2023.173531_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109153","article-title":"(2R,6R)-hydroxynorketamine rapidly potentiates optically-evoked schaffer collateral synaptic activity","volume":"214","author":"Riggs","year":"2022","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2023.173531_bb0855","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.psychres.2015.10.032","article-title":"Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression","volume":"230","author":"Romeo","year":"2015","journal-title":"Psychiatry Res."},{"issue":"11","key":"10.1016\/j.pbb.2023.173531_bb0860","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb0865","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/npp.2016.224","article-title":"Adjunctive lanicemine (AZD6765) in patients with major depressive disorder and history of inadequate response to antidepressants: a randomized, placebo-controlled study","volume":"42","author":"Sanacora","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.pbb.2023.173531_bb0870","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/mp.2013.130","article-title":"Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects","volume":"19","author":"Sanacora","year":"2014","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.pbb.2023.173531_bb0875","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.pbb.2023.173531_bb0880","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1176\/appi.ajp.2019.19040423","article-title":"A word to the wise about intranasal esketamine","volume":"176","author":"Schatzberg","year":"2019","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.pbb.2023.173531_bb0885","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1046\/j.1471-4159.1994.63020769.x","article-title":"3,5-dihydroxyphenylglycine is a highly selective agonist for phosphoinositide-linked metabotropic glutamate receptors in the rat hippocampus","volume":"63","author":"Schoepp","year":"1994","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.pbb.2023.173531_bb0890","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0028-3908(96)00121-9","article-title":"The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptors","volume":"35","author":"Schoepp","year":"1996","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb0895","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/BF02245860","article-title":"Onset and time course of antidepressant action: psychopharmacological implications of a controlled trial of electroconvulsive therapy","volume":"119","author":"Segman","year":"1995","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb0900","first-page":"993","article-title":"AMPA receptor-mTORC1 signaling activation is required for neuroplastic effects of LY341495 in rat hippocampal neurons","volume":"10","author":"Seo","year":"2020","journal-title":"Sci. Reports"},{"key":"10.1016\/j.pbb.2023.173531_bb0905","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuropharm.2019.04.019","article-title":"Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine","volume":"153","author":"Shaffer","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2023.173531_bb0910","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1146\/annurev.cellbio.23.090506.123516","article-title":"The cell biology of synaptic plasticity: AMPA receptor trafficking","volume":"23","author":"Shepherd","year":"2007","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"19","key":"10.1016\/j.pbb.2023.173531_bb0915","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1523\/JNEUROSCI.17-19-07503.1997","article-title":"Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus","volume":"17","author":"Shigemoto","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2023.173531_bb0920","series-title":"Side-effects associated with ketamine use in depression: a systematic review","author":"Short","year":"2017"},{"issue":"10","key":"10.1016\/j.pbb.2023.173531_bb0925","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1176\/appi.ajp.2016.16040411r","article-title":"Antidepressant efficacy and dosing comparisons of ketamine enantiomers: response to Hashimoto","volume":"173","author":"Singh","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.pbb.2023.173531_bb0930","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.biopsych.2015.10.018","article-title":"Intravenous esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled study","volume":"80","author":"Singh","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173531_bb0935","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-3-540-74806-9_15","article-title":"Ketamine","volume":"182","author":"Sinner","year":"2008","journal-title":"Handb. Exp Pharmacol"},{"issue":"6039","key":"10.1016\/j.pbb.2023.173531_bb0940","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/317717a0","article-title":"Glutamate stimulates inositol phosphate formation in striatal neurones","volume":"317","author":"Sladeczek","year":"1985","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.pbb.2023.173531_bb0945","doi-asserted-by":"crossref","first-page":"966","DOI":"10.4088\/JCP.12m08252","article-title":"Antidepressant augmentation using the N-methyl-D-aspartate antagonist memantine: a randomized, double-blind, placebo-controlled trial","volume":"74","author":"Smith","year":"2013","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.pbb.2023.173531_bb0950","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00001813-200606000-00001","article-title":"Recent developments in targeting the mammalian target of rapamycin (mTOR) kinase pathway","volume":"17","author":"Smolewski","year":"2006","journal-title":"Anti-Cancer Drugs"},{"issue":"6104","key":"10.1016\/j.pbb.2023.173531_bb0955","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/325531a0","article-title":"A new type of glutamate receptor linked to inositol phospholipid metabolism","volume":"325","author":"Sugiyama","year":"1987","journal-title":"Nature"},{"issue":"7659","key":"10.1016\/j.pbb.2023.173531_bb0960","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature22084","article-title":"Effects of a ketamine metabolite on synaptic NMDAR function","volume":"546","author":"Suzuki","year":"2017","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.pbb.2023.173531_bb0965","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tins.2015.03.003","article-title":"An excitatory synapse hypothesis of depression","volume":"38","author":"Thompson","year":"2015","journal-title":"Trends Neurosci."},{"issue":"7","key":"10.1016\/j.pbb.2023.173531_bb0970","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1111\/j.1476-5381.1995.tb15932.x","article-title":"Characterization of metabotropic glutamate receptor-stimulated phosphoinositide hydrolysis in rat cultured cerebellar granule cells","volume":"116","author":"Toms","year":"1995","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.pbb.2023.173531_bb0975","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S2215-0366(19)30394-3","article-title":"Esketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval","volume":"6","author":"Turner","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb0980","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0896-6273(00)80599-1","article-title":"A role for cAMP in long-term depression at hippocampal mossy fiber synapses","volume":"21","author":"Tzounopoulos","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.pbb.2023.173531_bb0985","doi-asserted-by":"crossref","first-page":"S447","DOI":"10.1016\/S0924-977X(15)30600-3","article-title":"P.2.F.021 results of a double-blind placebo-controlled study of the antidepressant effects of the mGLU2 negative allosteric modulator RG1578","volume":"25","author":"Umbricht","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.pbb.2023.173531_bb0990","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m12891","article-title":"Esketamine nasal spray plus Oral antidepressant in patients with treatment-resistant depression: assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)","volume":"81","author":"Wajs","year":"2020","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"10.1016\/j.pbb.2023.173531_bb0995","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/npp.2013.71","article-title":"NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL\/6J mice","volume":"38","author":"Walker","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.pbb.2023.173531_bb1000","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neuron.2011.09.023","article-title":"A critical role for GluN2B-containing NMDA receptors in cortical development and function","volume":"72","author":"Wang","year":"2011","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.pbb.2023.173531_bb1005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083941","article-title":"SynGAP regulates protein synthesis and homeostatic synaptic plasticity in developing cortical networks","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb1010","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2021.12.003","article-title":"BDNF signaling in context: from synaptic regulation to psychiatric disorders","volume":"185","author":"Wang","year":"2022","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pbb.2023.173531_bb1015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/ijnp\/pyab062","article-title":"Evaluation of the safety, tolerability, and pharmacokinetic profiles of TP0473292 (TS-161), a prodrug of a novel orthosteric mGlu2\/3 receptor antagonist TP0178894, in healthy subjects and its antidepressant-like effects in rodents","volume":"25","author":"Watanabe","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.pbb.2023.173531_bb1020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0167-8760(00)00173-2","article-title":"Inhibition-based rhythms: experimental and mathematical observations on network dynamics","volume":"38","author":"Whittington","year":"2000","journal-title":"Int. J. Psychophysiol."},{"issue":"2","key":"10.1016\/j.pbb.2023.173531_bb1025","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2017","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb1030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1124\/jpet.116.238121","volume":"361","author":"Witkin","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb1035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1124\/jpet.116.233627","article-title":"The rapidly acting antidepressant ketamine and the mGlu2\/3 receptor antagonist LY341495 rapidly engage dopaminergic mood circuits","volume":"358","author":"Witkin","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb1040","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S1734-1140(13)71080-6","article-title":"Involvement of NMDA and AMPA receptors in the antidepressant-like activity of antidepressant drugs in the forced swim test","volume":"65","author":"Wolak","year":"2013","journal-title":"Pharmacol. Rep."},{"issue":"12","key":"10.1016\/j.pbb.2023.173531_bb1045","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/s41380-018-0083-8","article-title":"NMDAR-independent, cAMP-dependent antidepressant actions of ketamine","volume":"24","author":"Wray","year":"2019","journal-title":"Mol. Psychiatry"},{"issue":"7","key":"10.1016\/j.pbb.2023.173531_bb1050","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s00213-022-06118-4","article-title":"Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors","volume":"239","author":"Wulf","year":"2022","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2023.173531_bb1055","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1124\/jpet.114.213959","article-title":"The [18F]FDG muPET readout of a brain activation model to evaluate the metabotropic glutamate receptor 2 positive allosteric modulator JNJ-42153605","volume":"350","author":"Wyckhuys","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2023.173531_bb1060","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuropharm.2017.10.008","article-title":"Hippocampal mTOR signaling is required for the antidepressant effects of paroxetine","volume":"128","author":"Xu","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2023.173531_bb1065","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2019.112708","article-title":"The antidepressant-like effects of fluvoxamine in mice involve the mTOR signaling in the hippocampus and prefrontal cortex","volume":"285","author":"Xu","year":"2020","journal-title":"Psychiatry Res."},{"issue":"9","key":"10.1016\/j.pbb.2023.173531_bb1070","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.biopsych.2010.06.016","article-title":"Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders","volume":"68","author":"Y\u00fcksel","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb1075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/03009734.2012.724118","article-title":"Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test","volume":"118","author":"Yang","year":"2013","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.pbb.2023.173531_bb1080","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"10","key":"10.1016\/j.pbb.2023.173531_bb1085","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1038\/mp.2017.239","article-title":"Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit","volume":"23","author":"Yao","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.pbb.2023.173531_bb1090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042676","article-title":"Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder","volume":"7","author":"Yoshida","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.pbb.2023.173531_bb1095","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/dneu.20765","article-title":"Post-synaptic BDNF-TrkB signaling in synapse maturation, plasticity and disease","volume":"70","author":"Yoshii","year":"2010","journal-title":"Dev. Neurobiol."},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb1100","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00213-006-0390-7","article-title":"An mGluR2\/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats","volume":"186","author":"Yoshimizu","year":"2006","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.pbb.2023.173531_bb1105","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1523\/JNEUROSCI.1316-22.2022","article-title":"NMDA receptor activation-dependent antidepressant-relevant behavioral and synaptic actions of ketamine","volume":"43","author":"Zanos","year":"2023","journal-title":"The Journal of Neuroscience"},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb1110","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"14","key":"10.1016\/j.pbb.2023.173531_bb1115","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1111\/bph.14683","article-title":"(R)-ketamine exerts antidepressant actions partly via conversion to (2R,6R)-hydroxynorketamine, while causing adverse effects at sub-anaesthetic doses","volume":"176","author":"Zanos","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"7604","key":"10.1016\/j.pbb.2023.173531_bb1125","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.pbb.2023.173531_bb1120","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1073\/pnas.1819540116","article-title":"(2R,6R)-hydroxynorketamine exerts mGlu(2) receptor-dependent antidepressant actions","volume":"116","author":"Zanos","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7659","key":"10.1016\/j.pbb.2023.173531_bb1130","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1038\/nature22085","article-title":"Zanos et al. reply","volume":"546","author":"Zanos","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pbb.2023.173531_bb1135","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."},{"issue":"11","key":"10.1016\/j.pbb.2023.173531_bb1140","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pbb.2023.173531_bb1145","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.biopsych.2012.10.019","article-title":"A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression","volume":"74","author":"Zarate","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.pbb.2023.173531_bb1150","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2023.173531_bb1155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1176\/appi.ajp.163.1.153","article-title":"A double-blind, placebo-controlled study of memantine in the treatment of major depression","volume":"163","author":"Zarate","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173531_bb1160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pbb.2013.11.033","article-title":"R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine","volume":"116","author":"Zhang","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"458","key":"10.1016\/j.pbb.2023.173531_bb1165","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aai7884","article-title":"Essential roles of AMPA receptor GluA1 phosphorylation and presynaptic HCN channels in fast-acting antidepressant responses of ketamine","volume":"9","author":"Zhang","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.pbb.2023.173531_bb1170","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbr.2016.09.002","article-title":"Differential regulation of GluA1 expression by ketamine and memantine","volume":"316","author":"Zhang","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2023.173531_bb1175","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jad.2020.01.002","article-title":"Adjunctive intranasal esketamine for major depressive disorder: a systematic review of randomized double-blind controlled-placebo studies","volume":"265","author":"Zheng","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pbb.2023.173531_bb1180","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2147\/NDT.S278422","article-title":"(2R,6R)-hydroxynorketamine alleviates electroconvulsive shock-induced learning impairment by inhibiting autophagy","volume":"17","author":"Zhong","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"7","key":"10.1016\/j.pbb.2023.173531_bb1185","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.eurpsy.2013.10.005","article-title":"Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex","volume":"29","author":"Zhou","year":"2014","journal-title":"Eur. Psychiatry"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305723000187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305723000187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:44:55Z","timestamp":1758775495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305723000187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":238,"alternative-id":["S0091305723000187"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2023.173531","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of group II metabotropic glutamate receptors in ketamine's antidepressant actions","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2023.173531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173531"}}